Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00167167 · ClinicalTrials.gov registry record · NA
Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia
A NA study, sponsored by Masonic Cancer Center, University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00167167 is a NA study that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 40 participants.
The verdict
NCT00167167, a NA study, has completed, sponsored by Masonic Cancer Center, University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
In this study our hypothesis is that infusion of donor lymphocyte immune cells from the subject's bone marrow donor will activate the subject's immune system to attack their cancer.
Interventions
- PROCEDURE Donor Lymphocyte Infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 1995-12 |
| Est. Completion | 2006-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00167167
The ClinicalTrials.gov registry entry for NCT00167167 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Donor Lymphocyte Infusion is the first listed.
NCT00167167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00167167 about?
NCT00167167 is a clinical study titled "Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia". In this study our hypothesis is that infusion of donor lymphocyte immune cells from the subject's bone marrow donor will activate the subject's immune system to attack their cancer.
What is the current status of trial NCT00167167?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 1995-12. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00167167?
The interventions under investigation include: Donor Lymphocyte Infusion (PROCEDURE).
Who is sponsoring clinical trial NCT00167167?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.